Document ID: chunk:federal_register_of_legislation:F2019L00389:clause:2_7
Version: federal_register_of_legislation:F2019L00389
Segment Type: clause
Provision Reference: sch 2 cl 7
Character Range: 4156–5350

7  Requirements
 (1) The requirements in relation to blood and blood components are:
 (a) subject to subsection (2), those requirements specified in the Guide; and
 (b) those requirements specified in subsections (3) and (4).
 (2) The reference to 'tropical areas' in relation to the deferral period for the condition Tropical infections in Table 2.2. Conditions leading to temporary deferral (suspension) on page 253 of the Guide is to be taken not to include areas within Australia.
             Note: For the definition of Guide, see section 4.
 (3) Blood and blood components must only be manufactured from blood where samples of that blood test negative for HBV, HCV and HIV-1, using
       nucleic acid amplification technology.
 (4) Blood and blood components must not be manufactured from a donor:
 (a) who lived in, or visited, England, Scotland, Wales, Northern Ireland or the Isle of Man for a cumulative period of 6 months or more, at any time on or between 1 January 1980 and 31 December 1996; or
 (b) who received a transfusion or injection of blood or blood products while in England, Scotland, Wales, Northern Island or the Isle of Man, at any time on or after 1 January 1980.